183 related articles for article (PubMed ID: 19401796)
21. Alpha-1-antitrypsin and other proteinase inhibitors.
Miravitlles M
Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
[TBL] [Abstract][Full Text] [Related]
22. Augmentation therapy in alpha-1 antitrypsin deficiency.
Heresi GA; Stoller JK
Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
[TBL] [Abstract][Full Text] [Related]
23. Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.
Núñez A; Belmonte I; Miranda E; Barrecheguren M; Farago G; Loeb E; Pons M; Rodríguez-Frías F; Gabriel-Medina P; Rodríguez E; Genescà J; Miravitlles M; Esquinas C
Respir Res; 2021 Sep; 22(1):244. PubMed ID: 34526035
[TBL] [Abstract][Full Text] [Related]
24. Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.
Stoller JK; Rouhani F; Brantly M; Shahin S; Dweik RA; Stocks JM; Clausen J; Campbell E; Norton F
Chest; 2002 Jul; 122(1):66-74. PubMed ID: 12114340
[TBL] [Abstract][Full Text] [Related]
25. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
McElvaney NG
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
[TBL] [Abstract][Full Text] [Related]
26. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
27. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
Campos MA; Lascano J
Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
Franciosi AN; McCarthy C; McElvaney NG
Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
[TBL] [Abstract][Full Text] [Related]
29. Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic.
Herth FJF; Sandhaus RA; Turner AM; Sucena M; Welte T; Greulich T
Int J Chron Obstruct Pulmon Dis; 2021; 16():2983-2996. PubMed ID: 34754184
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.
Blanco I; Lara B; de Serres F
Orphanet J Rare Dis; 2011 Apr; 6():14. PubMed ID: 21486454
[TBL] [Abstract][Full Text] [Related]
31. Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema.
Traclet J; Delaval P; Terrioux P; Mornex JF
Rev Mal Respir; 2015 Apr; 32(4):435-46. PubMed ID: 25908241
[TBL] [Abstract][Full Text] [Related]
32. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
[TBL] [Abstract][Full Text] [Related]
33. Alpha 1-antitrypsin deficiency.
Ellett ML
Gastroenterol Nurs; 1991 Dec; 14(3):138-41. PubMed ID: 1760450
[TBL] [Abstract][Full Text] [Related]
34. Introducing standards of the best medical practice for patients with inherited alpha-1-antitrypsin deficiency in Central Eastern Europe.
Valiulis A; Utkus A; Stukas R; Valiulis A; Siderius L;
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):107-14. PubMed ID: 24798601
[TBL] [Abstract][Full Text] [Related]
35. Alpha1-antitrypsin deficiency: New therapies on the horizon.
Remih K; Amzou S; Strnad P
Curr Opin Pharmacol; 2021 Aug; 59():149-156. PubMed ID: 34256305
[TBL] [Abstract][Full Text] [Related]
36. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
Tonelli AR; Brantly ML
Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology and treatment of alpha 1-antitrypsin deficiency.
MacDonald JL; Johnson CE
Am J Health Syst Pharm; 1995 Mar; 52(5):481-9;quiz 544-5. PubMed ID: 7606551
[TBL] [Abstract][Full Text] [Related]
38. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency.
Stockley RA; Bayley DL; Unsal I; Dowson LJ
Am J Respir Crit Care Med; 2002 Jun; 165(11):1494-8. PubMed ID: 12045122
[TBL] [Abstract][Full Text] [Related]
39. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
40. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]